Search

Restoring Effective Anti-Tumor Response in Hodgkin Lymphoma with Nivolumab

Hodgkin Lymphoma typically affects young men and women in their 30s. Although it is highly curable with the current combination of chemo and radiation therapy, approximately 20% of patients will not be cured with first line regimens.

Read more

A new form of inherited thrombocytopenia (ETV6-related thrombocytopenia, ETV6-RT): NEVER JUDGE A BOOK BY ITS COVER!

A new form of inherited thrombocytopenia (ETV6-related thrombocytopenia, ETV6-RT): NEVER JUDGE A BOOK BY ITS COVER!

We recently discovered a new form of an inherited deficiency of platelets (inherited thrombocytopenia-IT), which is caused by mutations in the ETV6-gene.

Read more

International Call to Action to Alleviate Drug Shortages

The common call to action seeks first to raise awareness of shortages of drugs among hematologists.

Read more

EHA-HSHT Joint Membership

Join EHA and HSHT to receive up to €50 discount on your membershipThe European Hematology Association (EHA) and the Hungarian Society of Hematology and Transfusion (HSHT) - Magyar Hematológiai és Transzfuziológiai Társaság – MHTT, have joined forces to offer joint membership to…

Read more

SPC Advisory Board, EHA Congress 2024

Current committee members
Valentine Brousse, France
Veronika Buxhofer-Ausch, Austria
Ana Cvejic, Denmark
Mattia D'Agostino, Italy
Thierry Facon, France
Krystof Giannopoulos, Poland
Julia Hauer, Germany
Dan Hodson, United Kingdom
Sören Lehmann, Sweden
Georg Lenz, Germany
Sirpa Leppä, Finland
Karina Meijer, The Netherlands
Emma Morris, United Kingdom
Cristina Papayannidis, Italy
France Pirenne, France
Delphine Rea, France
Sonata Šaulytė Trakymienė, Lithuania
Barbara…

Read more

Mini-hormone fights iron

Iron overload commonly leads to organ damage and even death. Currently available treatments for iron overload are burdensome or cause side effects.

Read more